IMMUNOHISTOCHEMICAL EVALUATION OF BONE-MARROW LYMPHOID NODULES IN CHRONIC MYELOPROLIFERATIVE DISORDERS

被引:16
|
作者
FRANCO, V [1 ]
FLORENA, AM [1 ]
ARAGONA, F [1 ]
CAMPESI, G [1 ]
机构
[1] UNIV PALERMO,IST ANAT PATOL,POLICLIN VIA VESPRO 129,I-90129 PALERMO,ITALY
关键词
LYMPHOID NODULES; CHRONIC MYELOPROLIFERATIVE DISORDERS; BONE MARROW; IMMUNOHISTOCHEMISTRY;
D O I
10.1007/BF01606516
中图分类号
R602 [外科病理学、解剖学]; R32 [人体形态学];
学科分类号
100101 ;
摘要
One hundred and seventy bone marrow biopsies from patients with chronic myeloproliferative disorders (CMPDs) were evaluated for the presence of lymphoid nodules (LNs) and were immunostained using a panel of monoclonal antibodies (UCHL1, 4KB5 and L26) recognizing different lymphocyte antigens. LNs were found in 35% of cases of idiopathic thrombocythaemia, 24.6% of myelofibrosis/osteomyelosclerosis, 18.2% of polycythaemia vera, 12.1% of chronic myeloid leukaemia and 19.2% of borderline cases. Varying degrees of immunohistochemical positivity for the three antibodies tested were found. LNs were always made up of variable proportions of both T- and B-lymphocytes with a prevalence of T-cells. This latter observation suggests that bone marrow LNs in CMPDs could be an expression of reactivity.
引用
收藏
页码:261 / 266
页数:6
相关论文
共 50 条
  • [41] BONE-MARROW IN MEGAKARYOCYTIC DISORDERS
    BURKHARDT, R
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1988, 2 (04) : 695 - 733
  • [42] LYMPHOPROLIFERATIVE DISORDERS IN THE BONE-MARROW
    BARTL, R
    FORTSCHRITTE DER MEDIZIN, 1982, 100 (03) : 65 - 65
  • [43] Biological and prognostic importance of apoptosis and proliferation in the bone marrow of chronic myeloproliferative disorders
    Kvasnicka, HM
    Thiele, J
    PATHOLOGE, 2000, 21 (01): : 55 - 62
  • [44] Chronic myeloproliferative disorders: the bone marrow stromal component is not involved in the malignant clone
    M Di Ianni
    L Moretti
    B Del Papa
    M De Ioanni
    E Bonifacio
    F Falzetti
    A Tabilio
    Leukemia, 2007, 21 : 377 - 378
  • [45] Chronic myeloproliferative disorders: the bone marrow stromal component is not involved in the malignant clone
    Di Ianni, M.
    Moretti, L.
    Del Papa, B.
    De Ioanni, M.
    Bonifacio, E.
    Falzetti, F.
    Tabilio, A.
    LEUKEMIA, 2007, 21 (02) : 377 - 378
  • [46] Diagnostic use of bone marrow cell cultures in patients with chronic myeloproliferative disorders
    Paszkowska-Kowalewska, M
    Swieboda-Sadley, A
    Dwilewicz-Trojaczek, J
    PROCEEDINGS OF THE XVII MEETING INTERNATIONAL SOCIETY OF HAEMATOLOGY (EUROPEAN AND AFRICAN DIVISION), 2003, : 169 - 173
  • [47] Bone marrow angiogenesis: methods of quantification and changes evolving in chronic myeloproliferative disorders
    Kvasnicka, HM
    Thiele, J
    HISTOLOGY AND HISTOPATHOLOGY, 2004, 19 (04) : 1245 - 1260
  • [48] MYELOID AND LYMPHOID RECONSTITUTION IN BONE-MARROW GRAFTS
    SYMANN, M
    HUMBLET, Y
    NOUVELLE REVUE FRANCAISE D HEMATOLOGIE, 1987, 29 (03): : 178 - 178
  • [49] BONE-MARROW AS A MAJOR LYMPHOID ORGAN IN RANA
    EIPERT, EF
    KLEMPAU, AE
    LALLONE, RL
    COOPER, EL
    CELLULAR IMMUNOLOGY, 1979, 46 (02) : 275 - 280
  • [50] LYMPHOID FOLLICLES IN BONE-MARROW ASPIRATES - REPLY
    MAEDA, K
    REBUCK, JW
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1977, 68 (02) : 315 - 316